Early ST elevation myocardial infarction in non-capable percutaneous coronary intervention centres:in situfibrinolysis vs. percutaneous coronary intervention transfer
Codi IAM
Male
Patient Transfer
Fibrinolysis
Middle Aged
STEMI network
Time-to-Treatment
3. Good health
STEMI
Hospitalization
03 medical and health sciences
Percutaneous Coronary Intervention
0302 clinical medicine
Spain
Humans
ST Elevation Myocardial Infarction
Female
Thrombolytic Therapy
Prospective Studies
Primary angioplasty
Retrospective Studies
DOI:
10.1093/eurheartj/ehv619
Publication Date:
2016-01-11T21:05:37Z
AUTHORS (13)
ABSTRACT
The preferred reperfusion strategy for early ST elevation myocardial infarction (STEMI, defined as time from symptoms onset ≤120 min) in non-capable percutaneous coronary intervention (PCI) centres remains controversial. We sought to compare mortality of situ fibrinolysis vs. PCI transfer a real-life consecutive cohort STEMI.Prospective multicentre STEMI registry (Catalonia 'Codi IAM' network) all-comers centre with symptom first medical contact (FMC) <120 min. Two groups were identified: and PCI-capable centre. Primary endpoint was 30-day mortality. included 2470 patients, whom 2227 (90.2%) 243 (9.8%) comprised the groups, respectively. In group, diagnostic system delays shorter (24 31 min, P < 0.001; 45 119 0.001, respectively). Thirty-day 7.7 5.1% respectively (P = 0.09). However, patients group whose FMC-device achieved within 140 min associated significantly lower (2.0% <99 4.6% 99-140 min; 0.01 0.03, fibrinolysis). multivariable logistic regression analysis, an independent predictive factor (odds ratio: 1.91, 95% confidence interval: 1.01-3.50; 0.04), together age Killip-Kimball class (both 0.001).In assisted centres, had worse prognosis than patient transfer. Transfer seems recommended delay <140
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (37)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....